Peptide Critic Community

And btw... I'm using peptidecritic v4 pen and would highly recommend that to anyone - bought more than one and love these peptide pens. Just so damn convenient (and not painful at all) over single injection syringe.

What you're really bringing to light and staying on in IMHO rightfully so - are the symptoms of internal operational issues that this vendor is having without you knowing exactly the source of their problems. But it's always the same... process and/or people. Everything else becomes a distraction.

There are many things within a company's control that directly impact the customer's experience and any vendor needs to get those right to have a chance for repeat business and success. Control what you can control. I hope Chimera can sort through their operational problems because they do offer good pricing and really seem to desire to do a good job. But desiring to do a good job only goes so far - the proof is in the delivery/execution.

Peptidecritic has been an invaluable resource for me in this peptide journey and I wish you & Randy much success now and for many years to come. Thanks for all you do for the peptide community.

@ResearchCat Wise advice! Great to get your testimonial on injecting cold - way more helpful to hear real life applications than from a machine for sure. I so appreciate Jeff paying for and sharing real testing results that gives me great confidence in my approach.

In pondering all of this, I really need to share the quiet part out loud. We are all taking the life of our Rat in our hands quite literally with each and every injection. And if, we notice "issues" with a transaction with any vendor (which have their root in operational issues)... in the back or maybe front of our semax/selank engaged brains we begin (or should) to question the quality of a product. Because where there is smoke there is fire. How is a company's QC when it comes to their product if the company is having such difficulty even clearly communicating to me or shipping the product I purchased?

Do I trust the vendor enough to take their product and inject it into my Rat? That's why Jeff articulates every chance he gets - trust but verify. The more problems a company exhibits the lower the trust goes. I hope this helps.

From Chimera website:
Notice

A Note for US Customers
April 22, 2026
·
3 min read
US shipments from our international catalog are on hold. This isn't a local issue with one courier or one port — Chinese peptide shipments are being blocked at every US entry point right now. Every vendor sourcing from overseas is in the same position.

International shipping to the rest of the world is unaffected. EU, UK, Canada, Australia, Asia, South America — everything ships as normal.

What changed
Three regulatory shifts have stacked on top of each other, and together they've effectively closed the overseas-to-US shipping channel for peptides:

CBP (US Customs) has shifted from targeted inspections to pattern-based detention across every major entry hub. The detection profiles are running everywhere simultaneously — there's no "quieter port" to route around.
FDA Import Alert 66-80 now allows automatic detention of peptide shipments from any manufacturer not on their approved Green List. Most overseas peptide producers aren't on that list.
The de minimis exemption for sub-$800 imports from China ended in 2025, which removed the lightweight path most direct-to-consumer vendors relied on.
Eight major US peptide vendors have shut down or paused in the last eight months — Peptide Sciences, Science.bio, Amino Asylum, and others. This isn't a Chimera problem. It's an industry-wide structural change.

Why we're not going anywhere
We've been around long enough to know that regulatory cycles like this follow a predictable pattern, even when the timing is uncertain:

First, enforcement tightens and shipments stop
Then, the market absorbs the change and new distribution models emerge
The vendors who survive are the ones with US-domestic inventory, not the ones relying on direct overseas shipping
We've been running a US Warehouse operation for a while specifically because this risk was always on the horizon. It's not a backup plan we're scrambling to build — it's already in place. The restocking path for our US Warehouse still runs through the same overseas supply chain, so there will be delays while the broader situation settles.

We are not shutting down. Not going anywhere. Not going to pretend this isn't happening.

What this means for you
If you have an open US order waiting to ship: Your payment isn't lost. We'll communicate with you directly. You can hold the order until the channel reopens, switch it to a US Warehouse equivalent if we stock it, or request a refund. Reply to your order confirmation email with your preference.
If you were about to place a US order: Hold off on the international catalog for now. If the product you want is in our US Warehouse catalog, that ships domestically in 1–2 business days and isn't affected by any of this.
If you want real-time updates: Discord is where we announce things first.
Timeline
We're not going to guess at a timeline. Anyone promising "two to four weeks" right now is either misinformed or lying. What we can tell you is this: we'll announce the moment anything changes, and we'll be honest about what we can and can't do in the meantime.

International customers
If you're outside the US, nothing changes. Orders ship on the usual schedule through the usual channels. The situation above is specific to US customs and FDA enforcement. It doesn't affect any other market.